Fig. 1

Immunohistochemical staining of pVEGFR-2 in tumor cells and inflammatory cells of CC tissue. a,b Characteristic pVEGFR-2^Tyr1175 expression in tumor cells with submembranous and nuclear immunostaining in the tumor center (a, x 200) and tumor budding regions (b, x 200). c,d Characteristic pVEGFR-2^Tyr1214 expression in tumor cells with submembranous and nuclear immunostaining in the tumor center (c, x 200) and tumor budding regions (d, x 200). e Characteristic VEGFR-2^Ty1175 expression in inflammatory cells (x 200). f Characteristic VEGFR-2^Ty1214 expression in inflammatory cells (x 200)